Senescence β-Galactosidase Staining Kit - Beyotime

Reporter gene assay β-galactosidase substrates - SK-Hep-1

Experiment
Reporter gene assay β-galactosidase substrates - SK-Hep-1
Product
Senescence β-Galactosidase Staining Kit - Beyotime from Beyotime
Manufacturer
Beyotime

Protocol tips

Protocol tips
Add 1 ml of the β-Galactosidase Staining Solution and incubate the plate at 37°C at least overnight in a dry incubator (no CO2)

Publication protocol

Senescent cells were analyzed using a SA β-gal staining kit (Beyotime Inc., Nantong, China) according to the manufacturer's instructions. The percentage of SA-β-gal positive cells was calculated by counting the cells in 5 random fields (at least 100 cells) using bright-field microscopy, according to the method reported by te Poele et al [41].

Full paper   Login or join for free to view the full paper.

Reviews

Senescence β-Galactosidase Staining Kit - Beyotime from Beyotime has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Reporter gene assay β-galactosidase substrates - SK-Hep-1 using Senescence β-Galactosidase Staining Kit - Beyotime from Beyotime.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Beyotime for Senescence β-Galactosidase Staining Kit - Beyotime below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Reporter gene assay β-galactosidase substrates - SK-Hep-1 using Senescence β-Galactosidase Staining Kit - Beyotime from Beyotime. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Become shareholder Discussions About us Contact Privacy Terms